聯合醫務(00722.HK):今年增2間影像中心 續尋求更多合作機會
聯合醫務(00722.HK)首席投資與項目高級總監張志華表示,集團將於今年新增兩間影像中心,位於彌敦道的中心會在下月開幕,另一間則於5月在美國銀行中心開業。他指出,後者為核子掃描中心,主營PET-CT業務,公私營醫院均有大量需求,因當中涉及輻射等因素,故選擇上亦有限制。不過,他對業務的收入有信心,預期項目可在兩年內錄得利潤。
張志華又指,目前集團尚未在新界建立醫療中心,惟認為新界有一定潛力及會作考慮。另外,集團現金流健康,惟暫時未有買舖計劃。
副主席及聯席行政總裁孫文堅稱,集團早前與港安醫院簽訂合作協議,日後不排除與更多醫院達成合作。集團亦有接收醫管局轉介個案,並會給予他們一定折扣。
孫文堅補充,集團有經營出國前體檢的業務,並留意到需求愈來愈大,相信是由於更多人選擇出國留學或移民。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.